Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 10 » default

Blood and Lymphatic Cancer: Targets and Therapy


Archive: Volume 10, 2020

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

Ujjani C, Mato A, Hill BT, Allan JN, Lansigan E, Jacobs R, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M

Blood and Lymphatic Cancer: Targets and Therapy 2020, 10:1-5

Published Date: 24 August 2020